Recent developments in tubulin polymerization inhibitors: An overview

European Journal of Medicinal Chemistry

Volumn 87, Issue , 2014, Pages 89-124

  Kaur, Ramandeep ^a   Kaur, Gurneet ^a   Gill, Rupinder Kaur ^a,b   Soni, Richard ^a   Bariwal, Jitender ^a  

^a ISF COLLEGE OF PHARMACY   (India)

^b I K GUJRAL PUNJAB TECHNICAL UNIVERSITY   (India)

Author keywords

Disruption of microtubules; Microtubules; Tubulin polymerization; Tubulin polymerization inhibitors

Indexed keywords

ALPHA TUBULIN; ANTIMITOTIC AGENT; ANTINEOPLASTIC AGENT; BENZIMIDAZOLE DERIVATIVE; BENZOFURAN DERIVATIVE; BETA TUBULIN; CHALCONE DERIVATIVE; CHROMENE DERIVATIVE; COLCHICINE DERIVATIVE; COMBRETASTATIN; GUANOSINE TRIPHOSPHATE; HETEROCYCLIC COMPOUND; INDOLE DERIVATIVE; NAPHTHALENE DERIVATIVE; PHENOTHIAZINE DERIVATIVE; PODOPHYLLOTOXIN; PYRAZOLE DERIVATIVE; QUINAZOLINE DERIVATIVE; STILBENE DERIVATIVE; TETRAHYDROISOQUINOLINE DERIVATIVE; THIAZOLE DERIVATIVE; TUBULIN MODULATOR; TUBULIN;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BROMINATION; CELL DIVISION; CELL FUNCTION; CELL STRUCTURE; CYTOTOXICITY; DEPOLYMERIZATION; DRUG BINDING SITE; DRUG MECHANISM; DRUG RESEARCH; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; G2 PHASE CELL CYCLE CHECKPOINT; MICROTUBULE; MICROTUBULE ASSEMBLY; MITOSIS INHIBITION; MITOSIS SPINDLE; POLYMERIZATION; STRUCTURE ACTIVITY RELATION; ANIMAL; DRUG EFFECTS; HUMAN; METABOLISM; MITOSIS;

ANIMALS; HUMANS; MICROTUBULES; MITOSIS; POLYMERIZATION; TUBULIN; TUBULIN MODULATORS;

EID: 84907535079     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2014.09.051     Document Type: Article

References (137)

1. http://schools.dcsd.k12.nv.us/dhs/class/MOLSEN/Life%20Science/Life%20Science/Unit%201/Chapter%209/9.3%20Mitosis%20cell%20division%20notes.pdf (2013). (accessed on 16.12.2013).
2. S.C. Ems-McClung C.E. Walczak Kinesin-13s in mitosis: key players in the spatial and temporal organization of spindle microtubules Semin. Cell. Dev. Boil 21 2010 276 282
3. http://biology.about.com/od/mitosisglossary/g/spindle-fibers.htm in, 2013. (accessed on 17.12.13).
4. http://answers.yahoo.com/question/index?qidCombining double low line20090105223715AAMrGyq, 2013. (accessed on 17.12.13).
5. http://geneticssuite.net/node/18, 2013. (accessed on 14.12.13).
6. S. Honore E. Pasquier D. Braguer Understanding microtubule dynamics for improved cancer therapy Cell. Mol. Life Sci. 62 2005 3039 3056
7. F. Pellegrini D.R. Budman Review: tubulin function, action of antitubulin drugs, and new drug development Cancer Invest. 23 2005 264 273
8. http://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?uidCombining double low line100015 2013. (accessed on 12.12.13).
9. R. Walker E. O'brien N. Pryer M. Soboeiro W. Voter H. Erickson E. Salmon Dynamic instability of individual microtubules analyzed by video light microscopy: rate constants and transition frequencies J. Cell. Biol. 107 1988 1437 1448
10. A. Akhmanova M.O. Steinmetz Tracking the ends: a dynamic protein network controls the fate of microtubule tips Nat. Rev. Mol. Cell. Biol. 9 2008 309 322
11. http://www.ncbi.nlm.nih.gov/books/NBK21580 2013. (accessed on 12.12.13).
12. http://www.ruf.rice.edu/g1/4bioslabs/studies/invertebrates/microtubules.html 2013. (accessed on 14.12.13).
13. C.A. Sontag J.T. Staley H.P. Erickson In vitro assembly and GTP hydrolysis by bacterial tubulins BtubA and BtubB J. Cell. Biol. 169 2005 233 238
14. T. David-Pfeuty H.P. Erickson D. Pantaloni Guanosinetriphosphatase activity of tubulin associated with microtubule assembly Proc. Natl. Acad. Sci. 74 1977 5372 5376
15. K. Gerdes M. Howard F. Szardenings Pushing and pulling in prokaryotic DNA segregation Cell 141 2010 927 942
16. M.W. Kirschner Implications of treadmilling for the stability and polarity of actin and tubulin polymers in vivo J. Cell. Biol. 86 1980 330 334
17. R.K. MacNeal D. Purich Stoichiometry and role of GTP hydrolysis in bovine neurotubule assembly J. Biol. Chem. 253 1978 4683 4687
18. T. Mitchison M. Kirschner Dynamic instability of microtubule growth Nature 312 1984 237 242
19. J. Howard A.A. Hyman Dynamics and mechanics of the microtubule plus end Nature 422 2003 753 758
20. K.H. Downing Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics 1 Annu. Rev. Cell. Dev. Biol. 16 2000 89 111
21. B. Gigant C. Wang R.B. Ravelli F. Roussi M.O. Steinmetz P.A. Curmi A. Sobel M. Knossow Structural basis for the regulation of tubulin by vinblastine Nature 435 2005 519 522
22. M. Jordan R. Margolis R. Himes L. Wilson Identification of a distinct class of vinblastine binding sites on microtubules J. Mol. Biol. 187 1986 61 73
23. F. Mollinedo C. Gajate Microtubules, microtubule-interfering agents and apoptosis Apoptosis 8 2003 413 450
24. E. Nogales S.G. Wolf K.H. Downing Structure of the 2 tubulin dimer by electron crystallography Nature 391 1998 199 203
25. R. Seidman I. Gitelman O. Sagi S.B. Horwitz M. Wolfson The role of ERK 1/2 and p38 MAP-kinase pathways in taxol-induced apoptosis in human ovarian carcinoma cells Exp. Cell. Res. 268 2001 84 92
26. S. Uppuluri L. Knipling D.L. Sackett J. Wolff Localization of the colchicine-binding site of tubulin Proc. Natl. Acad. Sci. 90 1993 11598 11602
27. S.L. Mooberry G. Tien A.H. Hernandez A. Plubrukarn B.S. Davidson Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents Cancer Res. 59 1999 653 660
28. R.B. Ravelli B. Gigant P.A. Curmi I. Jourdain S. Lachkar A. Sobel M. Knossow Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain Nature 428 2004 198 202
29. Q. Li H.L. Sham S.H. Rosenberg Antimitotic agents Annu. Rep. Med. Chem. 34 1999 139 148
30. M.A. Jordan R.J. Toso D. Thrower L. Wilson Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations Proc. Natl. Acad. Sci. 90 1993 9552 9556
31. P.G. Morris M.N. Fornier Microtubule active agents: beyond the taxane frontier Clin. Cancer Res. 14 2008 7167 7172
32. M.N. Bijman G.P. van Nieuw Amerongen N. Laurens V.W. van Hinsbergh E. Boven Microtubule-targeting agents inhibit angiogenesis at subtoxic concentrations, a process associated with inhibition of Rac1 and Cdc42 activity and changes in the endothelial cytoskeleton Mol. Cancer Ther. 5 2006 2348 2357
33. G.G. Dark S.A. Hill V.E. Prise G.M. Tozer G.R. Pettit D.J. Chaplin Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature Cancer Res. 57 1997 1829 1834
34. K. Hori S. Saito Microvascular mechanisms by which the combretastatin A-4 derivative AC7700 (AVE8062) induces tumour blood flow stasis Br. J. Cancer 89 2003 1334 1344
35. C. Kanthou G.M. Tozer The tumor vascular targeting agent combretastatin A-4-phosphate induces reorganization of the actin cytoskeleton and early membrane blebbing in human endothelial cells Blood 99 2002 2060 2069
36. L. Vincent P. Kermani L.M. Young J. Cheng F. Zhang K. Shido G. Lam H. Bompais-Vincent Z. Zhu D.J. Hicklin Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling J.Clin. Invest 115 2005 2992 3006
37. N. Klauber S. Parangi E. Flynn E. Hamel R.J. D'Amato Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol Cancer Res. 57 1997 81 86
38. S.L. Mooberry New insights into 2-methoxyestradiol, a promising antiangiogenic and antitumor agent Curr. Opin. Oncol. 15 2003 425 430
39. S. Stafford J. Schwimer C. Anthony J. Thomson Y. Wang E. Woltering Colchicine and 2-methoxyestradiol inhibit human angiogenesis J. Surg. Res. 125 2005 104 108
40. C. Da N. Telang P. Barelli X. Jia J.T. Gupton S.L. Mooberry G.E. Kellogg Pyrrole-based antitubulin agents: two distinct binding modalities are predicted for C-2 analogues in the colchicine site ACS Med. Chem. Lett. 3 2011 53 57
41. N. Dalyot-Herman F. Delgado-Lopez D.A. Gewirtz J.T. Gupton E.L. Schwartz Interference with endothelial cell function by JG-03-14, an agent that binds to the colchicine site on microtubules Biochem. Pharmacol. 78 2009 1167 1177
42. D.C. Blakey F.R. Westwood M. Walker G.D. Hughes P.D. Davis S.E. Ashton A.J. Ryan Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor models Clin. Cancer Res. 8 2002 1974 1983
43. P.D. Davis G.J. Dougherty D.C. Blakey S.M. Galbraith G.M. Tozer A.L. Holder M.A. Naylor J. Nolan M.R. Stratford D.J. Chaplin ZD6126 A novel vascular-targeting agent that causes selective destruction of tumor vasculature Cancer Res. 62 2002 7247 7253
44. G. Micheletti M. Poli P. Borsotti M. Martinelli B. Imberti G. Taraboletti R. Giavazzi Vascular-targeting activity of ZD6126, a novel tubulin-binding agent Cancer Res. 63 2003 1534 1537
45. B.C. Baguley K.M. Holdaway L.L. Thomsen L. Zhuang L. Jonathan Zwi Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: evidence for a vascular mechanism Eur. J. Cancer Clin. Oncol. 27 1991 482 487
46. A. Vacca M. Iurlaro D. Ribatti M. Minischetti B. Nico R. Ria A. Pellegrino F. Dammacco Antiangiogenesis is produced by nontoxic doses of vinblastine Blood 94 1999 4143 4155
47. S. Hill S. Lonergan J. Denekamp D. Chaplin Vinca alkaloids: anti-vascular effects in a murine tumour Eur. J. Cancer 29 1993 1320 1324
48. S. Honoré A. Pagano G. Gauthier V. Bourgarel-Rey P. Verdier-Pinard K. Civiletti A. Kruczynski D. Braguer Antiangiogenic vinflunine affects EB1 localization and microtubule targeting to adhesion sites Mol. Cancer Ther. 7 2008 2080 2089
49. B. Pourroy S. Honoré E. Pasquier V. Bourgarel-Rey A. Kruczynski C. Briand D. Braguer Antiangiogenic concentrations of vinflunine increase the interphase microtubule dynamics and decrease the motility of endothelial cells Cancer Res. 66 2006 3256 3263
50. J.A. Hohneker A summary of vinorelbine (navelbine) safety data from North American clinical trials Semin. Oncol. 21 1994 42 46
51. P. Mangeney R. Andriamialisoa J.-Y. Lallemand N. Langlois Y. Langlois P. Potier 5'-Nor anhydrovinblastine: prototype of a new class of vinblastine derivatives Tetrahedron 35 1979 2175 2179
52. G. Kaur M. Hollingshead S. Holbeck V. Schauer-Vukasinovic R. Camalier A. Domling S. Agarwal Biological evaluation of tubulysin A: a potential anticancer and antiangiogenic natural product Biochem. J. 396 2006 235 242
53. S. Mahboobi A. Sellmer T. Beckers Development of tubulin inhibitors as antimitotic agents for cancer therapy Stud. Nat. Prod. Chem. 33 2006 719 750
54. S.M. Rubenstein V. Baichwal H. Beckmann D.L. Clark W. Frankmoelle D. Roche E. Santha S. Schwender M. Thoolen Q. Ye Hydrophilic, pro-drug analogues of T138067 are efficacious in controlling tumor growth in vivo and show a decreased ability to cross the blood brain barrier J. Med. Chem. 44 2001 3599 3605
55. K.A. Gelmon K. Belanger D. Soulieres C. Britten S. Chia D. Charpentier K. Chi J. Powers W. Walsh L. Seymour A phase I study of T900607 given once every 3 weeks in patients with advanced refractory cancers; national cancer institute of Canada clinical trials group (NCIC-CTG) IND 130 Invest. New. Drugs 23 2005 445 453
56. T.L. Nguyen C. McGrath A.R. Hermone J.C. Burnett D.W. Zaharevitz B.W. Day P. Wipf E. Hamel R. Gussio A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach J. Med. Chem. 48 2005 6107 6116
57. K. Margolin J. Longmate T.W. Synold D.R. Gandara J. Weber R. Gonzalez M.J. Johansen R. Newman T. Baratta J.H. Doroshow Dolastatin-10 in metastatic melanoma: a phase II and pharmokinetic trial of the California Cancer Consortium Invest. New. Drugs 19 2001 335 340
58. B. Nuijen M. Bouma C. Manada J. Jimeno J.H. Schellens A. Bult J. Beijnen Pharmaceutical development of anticancer agents derived from marine sources Anti-cancer Drugs 11 2000 793 811
59. E.D. Saad E.H. Kraut P.M. Hoff D.F. Moore Jr. D. Jones R. Pazdur J.L. Abbruzzese Phase II study of dolastatin-10 as first-line treatment for advanced colorectal cancer Am. J. Clin. Oncol. 25 2002 451 453
60. K. Aoki K. Watanabe M. Sato M. Ikekita T. Hakamatsuka T. Oikawa Effects of rhizoxin, a microbial angiogenesis inhibitor, on angiogenic endothelial cell functions Eur. J. Pharmacol. 459 2003 131 138
61. A. Kiselyov K.V. Balakin S.E. Tkachenko N. Savchuk A.V. Ivachtchenko Recent progress in discovery and development of antimitotic agents Anti-Cancer Agents Med. Chem. 7 2007 189 208
62. K. Mross W. Berdel H. Fiebig R. Velagapudi I. Von Broen C. Unger Clinical and pharmacologic phase I study of cemadotin-HCI (LU103793), a novel antimitotic peptide, given as 24-hour infusion in patients with advanced cancer A study of the arbeitsgemeinschaft internistische onkologie (AIO) phase I group and arbeitsgruppe pharmakologie in der onkologie und haematologie (APOH) group of the German cancer society Ann. Oncol. 9 1998 1323 1330
63. R.S. Al-awar T.H. Corbett J.E. Ray L. Polin J.H. Kennedy M.M. Wagner D.C. Williams Biological evaluation of cryptophycin 52 fragment A analogues: effect of the multidrug resistance ATP binding cassette transporters on antitumor activity Mol. Cancer Ther. 3 2004 1061 1067
64. A. Rai A. Surolia D. Panda An antitubulin agent BCFMT inhibits proliferation of Cancer cells and induces cell death by inhibiting microtubule dynamics PloS One 7 2012
65. C. Twelves J. Cortes L.T. Vahdat J. Wanders C. Akerele P.A. Kaufman Phase III trials of eribulin mesylate (E7389) in extensively pretreated patients with locally recurrent or metastatic breast cancer Clin. Breast Cancer 10 2010 160 163
66. L.A. Amos What tubulin drugs tell us about microtubule structure and dynamics Semin. Cell. Dev. Boil 22 2011 916 926
67. Y. Lu J. Chen M. Xiao W. Li D.D. Miller An overview of tubulin inhibitors that interact with the colchicine binding site Pharm. Res. 29 2012 2943 2971
68. E. Von Angerer New inhibitors of tubulin polymerisation Expert Opin. Ther. Pat. 9 1999 1069 1081
69. J. Chen T. Liu X. Dong Y. Hu Recent development and SAR analysis of colchicine binding site inhibitors Mini Rev. Med. Chem. 9 2009 1174 1190
70. P.H. Jalily J.A. Hadfield N. Hirst S.B. Rossington Novel cyanocombretastatins as potent tubulin polymerisation inhibitors Bioorg. Med. Chem. Lett. 22 2012 6731 6734
71. S. Parihar A. Kumar A.K. Chaturvedi N.K. Sachan S. Luqman B. Changkija M. Manohar O. Prakash D. Chanda F. Khan Synthesis of combretastatin A4 analogues on steroidal framework and their anti-breast cancer activity J. Steroid. Biochem. Mol. Biol. 137 2013 332 344
72. A. Suresh Kumar M. Amarnath Reddy N. Jain C. Kishor T. Ramalinga Murthy D. Ramesh B. Supriya A. Addlagatta S.V. Kalivendi B. Sreedhar Design and synthesis of biaryl aryl stilbenes/ethylenes as antimicrotubule agents Eur. J. Med. Chem. 60 2012 305 324
73. S. Kumar S. Mehndiratta K. Nepali M.K. Gupta S. Koul P.R. Sharma A.K. Saxena K.L. Dhar Novel indole-bearing combretastatin analogues as tubulin polymerization inhibitors Org. Med. Chem. Lett. 3 2013 1 13
74. C. Dyrager M. Wickström M. Fridén-Saxin A. Friberg K. Dahlén E.A. Wallén J. Gullbo M. Grøtli K. Luthman Inhibitors and promoters of tubulin polymerization: synthesis and biological evaluation of chalcones and related dienones as potential anticancer agents Bioorg. Med. Chem. 19 2011 2659 2665
75. H. Ye A. Fu W. Wu Y. Li G. Wang M. Tang S. Li S. He S. Zhong H. Lai Cytotoxic and apoptotic effects of constituents from Millettia pachycarpa Benth Fitoterapia 83 2012 1402 1408
76. G. Wang F. Peng D. Cao Z. Yang X. Han J. Liu W. Wu L. He L. Ma J. Chen Design, synthesis and biological evaluation of millepachine derivatives as a new class of tubulin polymerization inhibitors Bioorg. Med. Chem. 2013 6844 6854
77. M.D. Vitorovic-Todorovic A. Eric-Nikolic B. Kolundzija E. Hamel S. Ristic I.O. Juranic B.J. Drakulic (E)-4-aryl-4-oxo-2-butenoic acid amides, chalcone aroylacrylic acid chimeras: design, antiproliferative activity and inhibition of tubulin polymerization Eur. J. Med. Chem. 62 2013 40 50
78. L.B. Salum W.F. Altei L.D. Chiaradia M.N. Cordeiro R.R. Canevarolo C.P. Melo E. Winter B. Mattei H.N. Daghestani M.C. Santos-Silva Cytotoxic 3, 4, 5-trimethoxychalcones as mitotic arresters and cell migration inhibitors Eur. J. Med. Chem. 63 2013 501 510
79. G. Wang F. Peng D. Cao Z. Yang X. Han J. Liu W. Wu L. He L. Ma J. Chen Design, synthesis and biological evaluation of millepachine derivatives as a new class of tubulin polymerization inhibitors Bioorg. Med. Chem. 21 2013 6844 6854
80. G. Wang C. Li L. He K. Lei F. Wang Y. Pu Z. Yang D. Cao L. Ma J. Chen Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents Bioorg. Med. Chem. 22 2014 2060 2079
81. R. Ailvarez P. Puebla J.F. Díaz A.C. Bento R. Garcia-Navas J. de la Iglesia-Vicente F. Mollinedo J.M. Andreu M. Medarde R. Pelaiez Endowing indole-based tubulin inhibitors with an anchor for derivatization: highly potent 3-Substituted indolephenstatins and indoleisocombretastatins J. Med. Chem. 56 2013 2813 2827
82. P. De M. Baltas D. Lamoral-Theys C. Bruyère R. Kiss F. Bedos-Belval N. Saffon Synthesis and anticancer activity evaluation of 2-(4-alkoxyphenyl) cyclopropyl hydrazides and triazolo phthalazines Bioorg. Med. Chem. 18 2010 2537 2548
83. A. Kamal R. Reddy M. Vishnuvardhan R. Mahesh V. Lakshma Nayak S. Prabhakar C. Suresh Reddy Synthesis and biological evaluation of cinnamido linked benzophenone hybrids as tubulin polymerization inhibitors and apoptosis inducing agents Bioorg. Med. Chem. Lett. 24 2014 2309 2314
84. A.K. Franz S.O. Wilson Organosilicon molecules with medicinal applications J. Med. Chem. 56 2012 388 405
85. M. Nakamura D. Kajita Y. Matsumoto Y. Hashimoto Design and synthesis of silicon-containing tubulin polymerization inhibitors: replacement of the ethylene moiety of combretastatin A-4 with a silicon linker Bioorg. Med. Chem. 21 2013 7381 7391
86. E.D.A. dos Santos E. Hamel R. Bai J.C. Burnett C.S.S. Tozatti D. Bogo R.T. Perdomo A.M. Antunes M.M. Marques M.D.F. Matos Synthesis and evaluation of diarylsulfides and diaryl selenide compounds for antitubulin and cytotoxic activity Bioorg. Med. Chem. Lett. 23 2013 4669 4673
87. N. Ty R. Pontikis G.G. Chabot E. Devillers L. Quentin S. Bourg J.-C. Florent Synthesis and biological evaluation of enantiomerically pure cyclopropyl analogues of combretastatin A4 Bioorg. Med. Chem. 21 2012 1357 1366
88. F. Tripodi R. Pagliarin G. Fumagalli A. Bigi P. Fusi F. Orsini M. Frattini P. Coccetti Synthesis and biological evaluation of 1, 4-Diaryl-2-azetidinones as specific anticancer agents: activation of adenosine monophosphate activated protein kinase and induction of apoptosis J. Med. Chem. 55 2012 2112 2124
89. J. Liu C.-H. Zheng X.-H. Ren F. Zhou W. Li J. Zhu J.-G. Lv Y.-J. Zhou Synthesis and biological evaluation of 1-benzylidene-3, 4-dihydronaphthalen-2-one as a new class of microtubule-targeting agents J. Med. Chem. 55 2012 5720 5733
90. A. Andreani M. Granaiola A. Locatelli R. Morigi M. Rambaldi L. Varoli N. Calonghi C. Cappadone G. Farruggia C. Stefanelli Substituted 3-(5-imidazo [2, 1-b[ thiazolylmethylene)-2-indolinones and analogues: synthesis, cytotoxic activity, and study of the mechanism of action (1) J. Med. Chem. 55 2012 2078 2088
91. A. Andreani M. Granaiola A. Leoni A. Locatelli R. Morigi M. Rambaldi V. Garaliene W. Welsh S. Arora G. Farruggia Antitumor activity of new substituted 3-(5-Imidazo [2, 1-b[ thiazolylmethylene)-2-indolinones and study of their effect on the cell cycle 1 J. Med. Chem. 48 2005 5604 5607
92. E. Rasolofonjatovo O. Provot A. Hamze J. Rodrigo J. Bignon J. Wdzieczak-Bakala D. Desravines J. Dubois J.-D. Brion M. Alami Conformationally restricted naphthalene derivatives type iso-combretastatin A-4 and iso-erianin analogues: synthesis, cytotoxicity and antitubulin activity Eur. J. Med. Chem. 52 2012 22 32
93. J. Zhou P. Giannakakou Targeting microtubules for cancer chemotherapy Curr. Med. Chem. Anti Cancer Agents 5 2005 65 71
94. X. Zhang J. Zhang L. Tong Y. Luo M. Su Y. Zang J. Li W. Lu Y. Chen The discovery of colchicine-SAHA hybrids as a new class of antitumor agents Bioorg. Med. Chem. 21 2013 3240 3244
95. M. Sriram J.J. Hall N.C. Grohmann T.E. Strecker T. Wootton A. Franken M.L. Trawick K.G. Pinney Design, synthesis and biological evaluation of dihydronaphthalene and benzosuberene analogs of the combretastatins as inhibitors of tubulin polymerization in cancer chemotherapy Bioorg. Med. Chem. 16 2008 8161 8171
96. M. LynnáTrawick An amino-benzosuberene analogue that inhibits tubulin assembly and demonstrates remarkable cytotoxicity Med. Chem. Comm. 3 2012 720 724
97. R.P. Tanpure C.S. George T.E. Strecker L. Devkota J.K. Tidmore C.-M. Lin C.A. Herdman M.T. MacDonough M. Sriram D.J. Chaplin Synthesis of structurally diverse benzosuberene analogues and their biological evaluation as anti-cancer agents Bioorg. Med. Chem. 21 2013 8019 8032
98. J. Zhou J. Jin Y. Zhang Y. Yin X. Chen B. Xu Synthesis and antiproliferative evaluation of novel benzoimidazole-contained oxazole-bridged analogs of combretastatin A-4 Eur. J. Med. Chem. 68 2013 222 232
99. A. Kamal A.B. Shaik N. Jain C. Kishor A. Nagabhushana B. Supriya G.B. Kumar S.S. Chourasiya Y. Suresh R.K. Mishra Design and synthesis of pyrazole-oxindole conjugates targeting tubulin polymerization as new anticancer agents Eur. J. Med. Chem. 2013
100. R. Romagnoli P.G. Baraldi M.K. Salvador M. Encarnacion Camacho D. Preti M.A. Tabrizi M. Bassetto A. Brancale E. Hamel R. Bortolozzi Synthesis and biological evaluation of 2-Substituted-4-(3g?2, 4g?2, 5g?2-trimethoxyphenyl)-5-Aryl thiazoles as anticancer agents Bioorg. Med. Chem. 20 2012 7083 7094
101. M. Salehi M. Amini S.N. Ostad G.H. Riazi A. Assadieskandar B. Shafiei A. Shafiee Synthesis, cytotoxic evaluation and molecular docking study of 2-alkylthio-4-(2, 3, 4-trimethoxyphenyl)-5-aryl-thiazoles as tubulin polymerization inhibitors Bioorg. Med. Chem. 21 2013 7648 7654
102. R. Romagnoli P.G. Baraldi M.K. Salvador D. Preti M. Aghazadeh Tabrizi A. Brancale X.-H. Fu J. Li S.-Z. Zhang E. Hamel Discovery and optimization of a series of 2-aryl-4-amino-5-(3g?2, 4g?2, 5g?2-trimethoxybenzoyl) thiazoles as novel anticancer agents J. Med. Chem. 55 2012 5433 5445
103. Ø.W. Akselsen K. Odlo J.-J. Cheng G. Maccari M. Botta T.V. Hansen Synthesis, biological evaluation and molecular modeling of 1, 2, 3-triazole analogs of combretastatin A-1 Bioorg. Med. Chem. 20 2012 234 242
104. B.C. Das X.-Y. Tang P. Rogler T. Evans Design and synthesis of 3, 5-disubstituted boron-containing 1, 2, 4-oxadiazoles as potential combretastatin A-4 (CA-4) analogs Tetrahedron. Lett. 53 2012 3947 3950
105. T.M. Beale D.M. Allwood A. Bender P.J. Bond J.D. Brenton D.S. Charnock-Jones S.V. Ley R.M. Myers J.W. Shearman J. Temple A-ring dihalogenation increases the cellular activity of combretastatin-templated tetrazoles ACS Med. Chem. Lett. 3 2012 177 181
106. R. Romagnoli P.G. Baraldi M.K. Salvador D. Preti M. Aghazadeh Tabrizi A. Brancale X.-H. Fu J. Li S.-Z. Zhang E. Hamel Synthesis and evaluation of 1, 5-disubstituted tetrazoles as rigid analogues of combretastatin A-4 with potent antiproliferative and antitumor activity J. Med. Chem. 55 2011 475 488
107. X.-F. Wang E. Ohkoshi S. Wang E. Hamel K.F. Bastow S.L. Morris-Natschke K.-H. Lee L. Xie Synthesis and biological evaluation of n-alkyl-n-(4-methoxyphenyl) pyridin-2-amines as a new class of tubulin polymerization inhibitors Bioorg. Med. Chem. 21 2012 632 642
108. A. Kamal M. Ashraf M. Khan V.D. Nimbarte S. Faazil N. Subba Reddy S. Taj Synthesis and cytotoxic activity of 2-anilinopyridine-3-acrylamides as tubulin polymerization inhibitors, Chem Med Chem 2014
109. S. Zheng Q. Zhong M. Mottamal Q. Zhang C. Zhang E. LeMelle H. McFerrin G. Wang Design, synthesis, and biological evaluation of novel pyridine-bridged analogs of combretastatin-A4 as anti-cancer agents J. Med. Chem. 57 2014 3369 3381
110. M.T. MacDonough T.E. Strecker E. Hamel J.J. Hall D.J. Chaplin M.L. Trawick K.G. Pinney Synthesis and biological evaluation of indole-based, anti-cancer agents inspired by the vascular disrupting agent 2-(3g?2-hydroxy-4g?2-methoxyphenyl)-3-(3 g?3, 4 g?3, 5 g?3-trimethoxybenzoyl)-6-methoxyindole (OXi8006) Bioorg. Med. Chem. 21 2013 6831 6843
111. D.-G. Zhao J. Chen Y.-R. Du Y.-Y. Ma Y.-X. Chen K. Gao B.-R. Hu Synthesis and structure-activity relationships of n-methyl-5, 6, 7-trimethoxylindoles as novel antimitotic and vascular disrupting agents J. Med. Chem. 56 2013 1467 1477
112. G. La Regina R. Bai W.M. Rensen E. Di Cesare A. Coluccia F. Piscitelli V. Famiglini A. Reggio M. Nalli S. Pelliccia Toward highly potent Cancer agents by modulating the C-2 group of the arylthioindole class of tubulin polymerization inhibitors J. Med. Chem. 56 2012 123 149
113. S. Chennamaneni B. Zhong R. Lama B. Su COX inhibitors indomethacin and sulindac derivatives as antiproliferative agents: synthesis, biological evaluation, and mechanism investigation Eur. J. Med. Chem. 56 2012 17 29
114. A. Kamal N. Reddy V.L. Nayak V.S. Reddy B. Prasad V.D. Nimbarte V. Srinivasulu M. Vishnuvardhan C.S. Reddy Synthesis and biological evaluation of benzo [ b[ furans as inhibitors of tubulin polymerization and inducers of apoptosis Chem Med Chem 9 2014 117 128
115. R. Romagnoli P.G. Baraldi M. Kimatrai Salvador D. Preti M. Aghazadeh Tabrizi M. Bassetto A. Brancale E. Hamel I. Castagliuolo R. Bortolozzi Synthesis and biological evaluation of 2-(alkoxycarbonyl)-3-anilinobenzo [ b[ thiophenes and thieno [2, 3-b[ pyridines as new potent anticancer agents J. Med. Chem. 56 2013 2606 2618
116. Y. Sun B. Pandit S.N. Chettiar J.P. Etter A. Lewis J. Johnsamuel P.-K. Li Design, synthesis and biological studies of novel tubulin inhibitors Bioorg. Med. Chem. Lett. 23 2013 4465 4468
117. A. Kamal M. Kashi Reddy T.B. Shaik Y. Srikanth V. Santhosh Reddy G. Bharath Kumar S.V. Kalivendi Synthesis of terphenyl benzimidazoles as tubulin polymerization inhibitors Eur. J. Med. Chem. 50 2012 9 17
118. X.-F. Wang S.-B. Wang E. Ohkoshi L.-T. Wang E. Hamel K. Qian S.L. Morris-Natschke K.-H. Lee L. Xie N-Aryl-6-methoxy-1, 2, 3, 4-tetrahydroquinolines: a novel class of antitumor agents targeting the colchicine site on tubulin Eur. J. Med. Chem. 67 2013 196 207
119. M.P. Leese F. Jourdan W. Dohle M.R. Kimberley M.P. Thomes R. Bai E. Hamel E. Ferrandis B.V.L. Potter Steroidomimetic tetraahydroisoquinolines for the design of new microtubule disruptors ACS Med. Chem. Lett. 3 2012 5 9
120. R. Aneja S.N. Vangapandu M. Lopus R. Chandra D. Panda H.C. Joshi Development of a novel nitro-derivative of noscapine for the potential treatment of drug-resistant ovarian cancer and T-cell lymphoma Mol. Pharmacol. 69 2006 1801 1809
121. N.K. Manchukonda B. Sridhar P.K. Naik H.C. Joshi S. Kantevari Copper (I) mediated facile synthesis of potent tubulin polymerization inhibitor, 9-amino-noscapine from natural noscapine Bioorg. Med. Chem. Lett. 22 2012 2983 2987
122. S.A. Patil J. Wang X.S. Li J. Chen T.S. Jones A. Hosni-Ahmed R. Patil W.L. Seibel W. Li D.D. Miller New substituted 4 H-chromenes as anticancer agents Bioorg. Med. Chem. Lett. 22 2012 4458 4461
123. V. Verones N. Flouquet M. Lecoeur A. Lemoine A. Farce B. Baldeyrou C. Mahieu N. Wattez A. Lansiaux J.-F. Goossens Synthesis, antiproliferative activity and tubulin targeting effect of acridinone and dioxophenothiazine derivatives Eur. J. Med. Chem. 59 2013 39 47
124. E. Rasolofonjatovo O. Provot A. Hamze J. Rodrigo J. Bignon J. Wdzieczak-Bakala C. Lenoir D. Desravines J. Dubois J.-D. Brion Design, synthesis and anticancer properties of 5-arylbenzoxepins as conformationally restricted iso-combretastatin A-4 analogues Eur. J. Med. Chem. 62 2013 28 39
125. J. Jiang B. Sun Y.-y. Wang M. Cui L. Zhang C.-z. Cui Y.-f. Wang X.-g. Liu H.-x. Lou Synthesis of macrocyclic bisbibenzyl derivatives and their anticancer effects as anti-tubulin agents Bioorg. Med. Chem. 20 2012 2382 2391
126. E. Raymond S. Faivre J.P. Armand Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy Drugs 60 2000 15 23
127. R. Sordella D.W. Bell D.A. Haber J. Settleman Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways Science 305 2004 1163 1167
128. V. Spanò A. Montalbano A. Carbone B. Parrino P. Diana G. Cirrincione I. Castagliuolo P. Brun O.-G. Issinger S. Tisi Synthesis of a new class of pyrrolo [3, 4-h[ quinazolines with antimitotic activity Eur. J. Med. Chem. 50 2013 2213 2224
129. A. Kamal M. Rao P. Das P. Swapna S. Polepalli V.D. Nimbarte K. Mullagiri J. Kovvuri N. Jain Synthesis and biological evaluation of imidazo [2, 1-b[[1, 3, 4] thiadiazole-linked oxindoles as potent tubulin polymerization inhibitors ChemMedChem. 9 2014 1463 1475
130. H. Stähblin Activity of a new glycosidic lignan derivative (VP 16-213) related to podophyllotoxin in experimental tumors Eur. J. Cancer 9 1965 1973, 215-221
131. K. Hande Etoposide: four decades of development of a topoisomerase II inhibitor Eur. J. Cancer 34 1998 1514 1521
132. A. Kamal J.R. Tamboli V. Lakshma Nayak S. Adil M. Vishnuvardhan S. Ramakrishna Synthesis of a terphenyl substituted 4-aza-2, 3-didehydropodophyllotoxin analogues as inhibitors of tubulin polymerisation and apoptosis inducers Bioorg. Med. Chem. 22 2014 2714 2723
133. T. Meng W. Wang Z. Zhang L. Ma Y. Zhang Z. Miao J. Shen Synthesis and biological evaluation of 6H-pyrido [2g?2, 1g?2: 2, 3] imidazo [4, 5-c[ isoquinolin-5 (6 H)-ones as antimitotic agents and inhibitors of tubulin polymerization Bioorg. Med. Chem. 22 2014 848 855
134. T. Meng Z. Zhang D. Hu L. Lin J. Ding X. Wang J. Shen Three-component combinatorial synthesis of a substituted 6 H-pyrido [2g?2, 1g?2: 2, 3] imidazo-[4, 5-c[ isoquinolin-5 (6 H)-one library with cytotoxic activity J. Comb. Chem. 9 2007 739 741
135. M.M. Kandeel A.M. Kamal E.K. Abdelall H.A. Elshemy Synthesis of novel chromene derivatives of expected antitumor activity Eur. J. Med. Chem. 59 2012 183 193
136. N. Zhang S. Ayral-Kaloustian T. Nguyen R. Hernandez C. Beyer 2-Cyanoaminopyrimidines as a class of antitumor agents that promote tubulin polymerization Bioorg. Med. Chem. Lett. 17 2007 3003 3005
137. F. Montel C. Lamberth P.M. Jung First synthesis of 7-amido-[1, 2, 4] triazolo [1, 5-a[ pyrimidines using halogen-metal exchange Tetrahedron 64 2008 6372 6376